• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Adjunctive ultrasonography increases detection rate of early breast cancer [J-START trial]

byMelissa McCoyandXiaozhou Liu
November 13, 2015
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, mammography with adjunctive ultrasonography was associated with significantly higher breast cancer detection rates than mammography alone (high sensitivity).

2. Specificity was lower for mammography with adjunctive ultrasonography than mammography alone. A detailed future analysis of risk and benefit is warranted to reduce screening-associated harm.

Evidence Rating Level: 1 (Excellent)

Study Rundown: This study aimed to assess the efficacy of screening for breast cancer with ultrasonography in addition to mammography in Japanese women aged 40-49 years. Women who had no history of cancer in the past five years and were expected to live for more than five years were eligible for participation in the study. Women were either assigned to the intervention group (ultrasound in addition to mammography) or to the control group (mammography alone). Sensitivity, specificity, cancer detection rate, and stage distribution at the first round of screening was the primary outcome. In the intervention group, sensitivity was significantly higher, whereas specificity was significantly lower. More cancers were detected in the intervention group and were more frequently stage 0 and I, though fewer interval cancers were detected in the intervention group. These results support ultrasound in combination with mammography as a low-cost way to increase sensitivity and detection rates of early cancers in women with dense breast tissue. This study had sufficient power to detect a meaningful difference in sensitivity and the results therefore provide strong evidence. A weakness of this design is that it cannot be generalized beyond the first round of screening, as sensitivity and specificity were calculated from first round screening.

The study was funded by Ministry of Health, Labour and Welfare of Japan.

Click to read the study in The Lancet

RELATED REPORTS

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

Relevant Reading: A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women

In-Depth [randomized controlled trial]: This randomized controlled trial aimed to assess the efficacy of screening for breast cancer with ultrasonography as an adjunctive to mammography in women 40-49 years with dense breast tissue. 72,998 Japanese women who had no history of cancer in the past five years and were expected to live for more than five years were enrolled in the study. 36,859 women were either assigned to the intervention group (ultrasonography plus mammography) and 36,139 women were assigned to the control group (mammography alone).  Each group received screening twice per year for two years.

In the intervention group, sensitivity was significantly higher than in the control group (91.1%, 95% CI 87.2-95.0 vs. 77.0%, 70.3-83.7; p=0.0004) but specificity was significantly lower than in the control group (87.7%, 87.3-88.0 vs. 91.1-91.7; p<0.0003). More cancers were detected in the intervention group and were more frequently stage 0 and I, though fewer interval cancers were detected in the intervention group (184 [0.50%] vs. 117 [0.32%], p=0.0003). Cancers detected in the intervention group were more frequently stage 0 and I (114 [71.3%] vs. 79 [52.0%], p=0.0194). In the intervention group, 18 (0.05%) interval cancers were detected compared with 35 (0.10%) in the control group (p=0.034).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancer
Previous Post

No benefit of continuous over interrupted chest compressions during CPR

Next Post

Risk of developing autoimmune diseases increased after childhood cancer

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Endocrinology

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

August 28, 2025
One-year of Herceptin preferable to two-year regimen
Endocrinology

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

August 28, 2025
USPSTF recommends chemoprevention for women at high risk for breast cancer
Endocrinology

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

August 26, 2025
Incidental findings common with breast imaging, often benign
Chronic Disease

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

August 21, 2025
Next Post

Risk of developing autoimmune diseases increased after childhood cancer

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

High fertilization rates following intracytoplasmic sperm injection (ICSI) [Classics Series]

Solitary kidney not associated with contrast-induced nephropathy

Solitary kidney not associated with contrast-induced nephropathy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Significant body weight reduction with cagrilintide-semaglutide therapy
  • Machine learning models diagnose celiac disease at similar performance levels to pathologists
  • Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.